NCT06369532

Brief Summary

This study aims to investigate whether the combination of transcranial Direct Current Stimulation (tDCS) and cognitive-behavioral therapy (CBT) is more effective for treating repetitive negative thinking (RNT) in patients with the symptom of high rumination. High ruminators will be included (Group1, active tDCS-CBT group; Group2, sham tDCS-CBT group). All patients will receive active or sham tDCS.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started Mar 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Mar 2024Dec 2027

First Submitted

Initial submission to the registry

January 22, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

March 6, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 17, 2024

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2027

Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

3.6 years

First QC Date

January 22, 2024

Last Update Submit

March 11, 2026

Conditions

Keywords

transcranial direct current stimulation

Outcome Measures

Primary Outcomes (2)

  • the therapeutic effect of the combination therapy for repetitive negative thinking

    Questionnaires including the Penn State Worry Questionnaire (PSWQ, range 16-80), the Leuven adaptation of the rumination on sadness Scale (LARSS, range 21-105) , and the Ruminative Response Scale (RRS, range 22-88) will be used to measure the alteration of repetitive negative thinking. Higher scores suggest a higher level of worry or rumination. The Beck Depression Inventory (BDI), the Hamilton Depression Rating Scale (HDRS) and other related questionnaires will also be included.

    Baseline, up to 7 weeks' therapy and up to 3 months' therapy

  • the consolidation effect of tDCS on CBT

    The Self-Critical Rumination scale (SCRS, range 0-40) and the Perseverative Thinking Questionnaire (PTQ, range 0-60) will be measures after each session (8 sessions in total). Higher scores suggest a higher level of self-critical ruminative thoughts or repetitive negative thinking.

    up to 7 weeks' therapy and up to 3 months' therapy

Secondary Outcomes (1)

  • Change of neuroimaging data

    Baseline and up to 3 months' therapy

Study Arms (2)

Active tDCS group

ACTIVE COMPARATOR

Patients will receive active tDCS during the therapy.

Device: Active tDCS

Sham tDCS group

SHAM COMPARATOR

Patients will receive sham tDCS during the therapy.

Device: Sham tDCS

Interventions

During the whole therapy period, active tDCS group will receive active tDCS after CBT. They also receive active home-based tDCS.

Active tDCS group
Sham tDCSDEVICE

The sham tDCS group will receive sham tDCS after CBT. They also receive sham home-based tDCS.

Sham tDCS group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Generalized anxiety disorder (GAD)
  • Depressive disorder

You may not qualify if:

  • other psychiatric pathology than GAD or depression screened by senior psychiatrist by means of the Mini-International Neuropsychiatric Interview (MINI) and psychiatric anamnesis
  • Abuse of alcohol, drugs or medication other than prescribed by general practitioner or psychiatrist
  • no consent to participate in measurement (questionnaire, fNIRS or EEG)
  • Insufficient knowledge of the current language (Dutch)
  • Acute or chronic suicidality
  • Acute psychosis or manic depressive disorder
  • Inability to commit to 8 sessions of Cognitive-Behavioral Therapy (CBT) or receive 4 weeks of transcranial Direct Current Stimulation (tDCS).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ghent

Ghent, East-Flanders, 9000, Belgium

RECRUITING

Related Publications (3)

  • Baeken C, Wu GR, Rogiers R, Remue J, Lemmens GM, Raedt R. Cognitive behavioral based group psychotherapy focusing on repetitive negative thinking: Decreased uncontrollability of rumination is related to brain perfusion increases in the left dorsolateral prefrontal cortex. J Psychiatr Res. 2021 Apr;136:281-287. doi: 10.1016/j.jpsychires.2021.02.011. Epub 2021 Feb 13.

  • Sathappan AV, Luber BM, Lisanby SH. The Dynamic Duo: Combining noninvasive brain stimulation with cognitive interventions. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:347-360. doi: 10.1016/j.pnpbp.2018.10.006. Epub 2018 Oct 9.

  • Dedoncker J, Baeken C, De Raedt R, Vanderhasselt MA. Combined transcranial direct current stimulation and psychological interventions: State of the art and promising perspectives for clinical psychology. Biol Psychol. 2021 Jan;158:107991. doi: 10.1016/j.biopsycho.2020.107991. Epub 2020 Nov 21.

Study Officials

  • Chris Baeken

    University Ghent

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
Participants will be allocated into two groups randomly (using a code). The psychotherapist, the study managers and the patients will not be aware of treatment allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2024

First Posted

April 17, 2024

Study Start

March 6, 2024

Primary Completion (Estimated)

September 26, 2027

Study Completion (Estimated)

December 20, 2027

Last Updated

March 12, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations